Impact of Formulation Choices on the Freeze-Drying of an Interleukin-6 Reference Material.

Matejtschuk, Paul; Bird, Christopher; Ezeajughi, Ernest; MacLellan-Gibson, Kirsty; Wadhwa, Meenu.

Afiliação

Matejtschuk P; Analytical and Biological Sciences, NIBSC, Medicines and Healthcare Products Regulatory Agency, Potters Bar, United Kingdom.
Bird C; Biotherapeutics, NIBSC, Medicines and Healthcare products Regulatory Agency, Potters Bar, United Kingdom.
Ezeajughi E; Analytical and Biological Sciences, NIBSC, Medicines and Healthcare Products Regulatory Agency, Potters Bar, United Kingdom.
MacLellan-Gibson K; Analytical and Biological Sciences, NIBSC, Medicines and Healthcare Products Regulatory Agency, Potters Bar, United Kingdom.
Wadhwa M; Biotherapeutics, NIBSC, Medicines and Healthcare products Regulatory Agency, Potters Bar, United Kingdom.

Front Mol Biosci ; 9: 868460, 2022.

Article em En | MEDLINE | ID: mdl-35860358